Cart
sales@molnova.com
Aspacytarabine
CAS No. 2098942-53-9
Aspacytarabine( Astarabine | BST-236 | BST236 )
Catalog No. M13324 CAS No. 2098942-53-9
Aspacytarabine (Astarabine, BST236) is a cytarabine conjugate that shows anti- neoplastic agents for inhibiting cancer cell growth.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAspacytarabine
-
NoteResearch use only, not for human use.
-
Brief DescriptionAspacytarabine (Astarabine, BST236) is a cytarabine conjugate that shows anti- neoplastic agents for inhibiting cancer cell growth.
-
DescriptionAspacytarabine (Astarabine, BST236) is a cytarabine conjugate that shows anti- neoplastic agents for inhibiting cancer cell growth. Blood Cancer Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsAstarabine | BST-236 | BST236
-
PathwayCell Cycle/DNA Damage
-
TargetNucleoside Antimetabolite/Analog
-
RecptorNucleoside Antimetabolite/Analog
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number2098942-53-9
-
Formula Weight358.3
-
Molecular FormulaC13H18N4O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN[C@@H](CC(NC(C=CN1[C@H]2[C@H]([C@@H]([C@@H](CO)O2)O)O)=NC1=O)=O)C(O)=O
-
Chemical NameN4-(1-β-D-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin-4-yl)-L-asparagine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. PCT Int. Appl. (2019), WO 2019012328 A1 20190117.
molnova catalog
related products
-
Isoguanine
Isoguanine is a purine base that is an isomer of guanine. A building block in organic synthesis.
-
7-Methylguanosine
7-Methylguanosine is a novel cNIIIB nucleotidase inhibitor (IC50 : 87.8?±?7.5?μM).
-
5-Fluorouracil
An uridine analog that is a widely used chemotherapeutic agent; affects pyrimidine synthesis by inhibiting thymidylate synthase (TS), inhibits DNA/RNA synthesis in cancer cells.
